Confession Time (that’s not what this blog is about?): For some time, I’ve been reading with some envy the excellent stories my colleagues have published with our ace data reporter, Madi Alexander. And I’ve been on the lookout for data that could turn into my own story.
This is kind of ironic, given the number of stories I write about data: data collection in research, real-world data to be used in clinical trials, fabrication, falsification and plagiarism of data in research misconduct stories, returning of research results…you get the idea.
Anyway, I was excited when I saw the report from the Health and Human Services Office of Inspector General’s report on the HHS Office for Human Research Protections. (Side note, we’ve known this report was coming for about two years, and I’ve been bugging the OIG’s press office for some time about it. So naturally it comes out the one Monday I took off this year).
This report primarily evaluated whether the OHRP is operating independently. Basically, the OIG said they’re doing the best they can, but Congress should give them more authority and more money to do more stuff independently. But in the back, the OIG included some neat data points showing a steep decline in the number of noncompliance allegations being pursued by the OHRP.
Madi agreed there was something to this. She did a really neat analysis that showed the number of allegations resulting in a compliance evaluation decreased by 51 percentage points—to 11 percent from 62 percent—between 2000 and 2015.
We talked to some the authors of the OIG report, the HHS, and Mike Carome, who used to be THE regulatory guy at the OHRP before he joined the watchdog group Public Citizen in 2010.
There are some other things there, too, but you have to read the story to find out.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)